Scenarios that move TECH

Bio-Techne Corp - Common Stock

Scenarios that move TECH: 1 analysis, 1 positive, 0 negative.

  1. · Zymeworks updates 2026 guidance after Theravance acquisition — ▲ · impact +22 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing